It’s creeping back quietly—no panic, no headlines screaming the way COVID once did—but tuberculosis is moving in the wrong direction again, and public health officials are starting to pay attention.
The Comeback Nobody Wanted
For years, TB in the United States felt like a solved problem—or at least a controlled one. Cases had been steadily declining since the early 1990s. Then something shifted.
According to provisional CDC data (available via https://www.cdc.gov/tb), the U.S. recorded 10,260 TB cases in 2025, continuing a steady climb that began around 2020. That may not sound massive in a country of 330 million, but the trend line is what’s worrying experts.
Take a look at how things have changed:
| Year | Reported TB Cases (U.S.) | Trend |
|---|---|---|
| 2019 | ~8,900 | Declining |
| 2020 | ~7,100 | Sharp drop (COVID disruption) |
| 2021 | ~7,800 | Rising again |
| 2023 | ~9,600 | Continued increase |
| 2025 | 10,260 | Highest in years |
New York alone reported 967 cases, underscoring how urban density still plays a role in transmission.
Globally, the situation is even more stark. TB reclaimed its position as the world’s deadliest infectious disease in 2023, overtaking COVID-19 after the pandemic years. The World Health Organization (https://www.who.int/news-room/fact-sheets/detail/tuberculosis) estimates 1.6 million deaths annually.
Why TB Is So Hard to Catch—Until It’s Not
One of the biggest problems with tuberculosis is how easily it hides.
At its core, TB is caused by Mycobacterium tuberculosis, a bacteria that spreads through the air when an infected person coughs, sneezes, or even talks. But unlike the flu or COVID, exposure doesn’t always mean immediate illness.
There are two very different scenarios:
| Condition | What Happens | Contagious? |
|---|---|---|
| Latent TB | Bacteria live in the body but stay inactive | No |
| Active TB | Bacteria multiply and cause symptoms | Yes |
Here’s the twist: up to 13 million people in the U.S. are estimated to have latent TB, according to the CDC. That’s a massive reservoir.
And about 5–10% of those cases will eventually become active, especially if the immune system weakens. That’s why over 80% of U.S. TB cases come from latent infections reactivating—not recent transmission.
The Symptoms People Miss
TB doesn’t announce itself loudly at first. It creeps in, often mistaken for something far less serious.
Early symptoms can look like a stubborn flu:
- Fever and chills
- Night sweats
- Fatigue
- Weight loss
When it hits the lungs—the most common form—it becomes more recognizable:
- Persistent cough lasting weeks
- Chest pain
- Coughing up blood or mucus
But TB doesn’t always stay in the lungs. It can spread almost anywhere:
- Brain → headaches, confusion
- Spine → back pain
- Kidneys → blood in urine
- Lymph nodes → swollen, discolored lumps
That variability is exactly why cases slip through the cracks. By the time it’s diagnosed, transmission may have already occurred.
Treatment Exists—But It’s Not Easy
Here’s the frustrating part: TB is both preventable and curable. But the treatment process is long and demanding.
Most patients need multiple antibiotics for 6 to 9 months, sometimes longer. And that’s where things break down.
Doctors say many patients:
- Start feeling better early
- Then stop taking medication
- Or struggle with side effects
That’s not just a personal health risk—it’s how drug-resistant TB emerges.
In 2023, the CDC reported 589 U.S. cases resistant to at least one key drug, complicating treatment and raising costs.
You can explore treatment guidelines through official CDC resources here: https://www.cdc.gov/tb/topic/treatment.
Why Cases Are Rising Again
There’s no single cause, but several factors are converging:
1. Pandemic Disruption
COVID-19 didn’t just kill millions—it disrupted routine healthcare. TB testing dropped, diagnoses were delayed, and latent infections went untreated.
2. Global Travel and Migration
TB remains widespread in parts of Asia, Africa, and Eastern Europe. Increased global movement means cases can cross borders more easily.
3. Missed or Delayed Diagnoses
Because symptoms mimic common illnesses, TB often isn’t caught early.
4. Treatment Drop-Off
Long treatment timelines lead to incomplete therapy, increasing both relapse and resistance.
How Dangerous Is It, Really?
TB is not just a historical disease—it’s still lethal.
Without treatment, about half of people with active TB will die, according to global health data.
The mechanism is brutal but slow. The bacteria destroy lung tissue, weaken the body, suppress appetite, and eventually lead to systemic failure.
And yet, with proper treatment, most patients recover.
That contrast—highly treatable but still deadly—is what makes TB so frustrating from a public health perspective.
Prevention: What Actually Works
In many countries, a vaccine called BCG is given at birth. But in the U.S., it’s not routinely used because TB risk is relatively low and the vaccine’s effectiveness in adults is inconsistent (CDC explanation: https://www.cdc.gov/tb/publications/factsheets/prevention/bcg.htm).
So prevention here relies on something less visible: early detection.
That includes:
- Testing high-risk individuals
- Treating latent TB before it activates
- Rapid diagnosis of active cases
- Good ventilation in shared spaces
- Masking in high-risk exposure settings
If someone with active TB goes untreated, they can infect 10–15 people per year on average.
